查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1578864

黃體酮市場：按類型、給藥方法和應用分類 - 2025-2030 年全球預測

Progesterone Market by Type (Natural Progesterone, Synthetic Progesterone), Mode of Delivery (Injectable, Oral, Suspended Form), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年黃體酮市值為13億美元，預計到2024年將達到14.7億美元，複合年成長率為13.39%，預計到2030年將達到31.4億美元。

黃體酮是生殖系統必需的激素，在調節月經週期和維持妊娠方面發揮重要作用，並用於多種治療。對黃體酮的需求超越了其生理作用，對於荷爾蒙補充療法、避孕藥、月經失調和某些癌症的治療也至關重要。最終用途範圍從製藥到生物技術，甚至獸醫學，反映了其多功能效用。根據市場洞察，生殖健康意識的提高、婦科疾病發病率的增加以及給藥系統的進步是黃體酮市場的關鍵成長要素。對生物同質激素和天然黃體酮不斷成長的需求代表著巨大的市場機會，以及在新治療領域擴大應用的潛力。公司可以透過投資創新配方和藥物輸送技術、確保遵守監管標準並專注於有關荷爾蒙療法的消費者教育來抓住這些機會。然而，市場並非沒有挑戰。嚴格的監管要求、與合成產品相關的副作用以及來自替代療法的競爭是顯著的限制因素。新興市場的價格敏感度和複雜的原料供應鏈動態也阻礙了成長潛力。為了克服這些挑戰，需要加強對更安全、更有效的合成和生物同質製劑的研究。此外，個人化醫療和生物技術的進步為創新提供了肥沃的土壤。儘管市場競爭激烈，但對於能夠透過策略聯盟、專注於利基市場並利用技術來提高產品功效和安全性來應對這些複雜性的公司來說，機會還是很多的。透過預測監管變化並提供符合消費者偏好的產品，公司可以維持成長並利用黃體酮市場的新趨勢。

主要市場統計
基準年[2023] 13億美元
預測年份 [2024] 14.7億美元
預測年份 [2030] 31.4億美元
複合年成長率（%） 13.39%

市場動態：揭示快速發展的黃體酮市場的關鍵市場洞察

黃體酮市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

波特五力：駕馭黃體素市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解黃體素市場的外部影響

外部宏觀環境因素在塑造黃體酮市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解黃體素市場的競爭格局

對黃體酮市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣：黃體素市場供應商績效評估

FPNV定位矩陣是評估黃體素市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製黃體素市場的成功之路

黃體酮市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料以及對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 月經、乳癌和愛滋病的發生率增加
      • 全球女性不孕率上升
      • 婦科治療多樣化導致需求增加
    • 抑制因素
      • 對黃體酮和黃體素副作用的擔憂
    • 機會
      • 醫療領域的技術進步
      • 正在進行的研究和開發活動
    • 任務
      • 對荷爾蒙療法缺乏認知
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會的
    • 技術的
    • 合法的
    • 環境的

第6章黃體酮市場：依類型

  • 天然黃體酮
  • 合成黃體酮

第7章 黃體素市場：依管理方式分類

  • 注射
  • 口服劑
  • 暫停

第8章黃體酮市場：依應用分類

  • 避孕
  • 子宮功能障礙出血
  • 子宮內膜癌
  • 增生性前驅病變
  • 調整月經週期

第9章美洲黃體酮市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區黃體素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲黃體酮市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Alkem Laboratories Ltd.
  • Aquatic Remedies Pvt. Ltd
  • Bionpharma, Inc.
  • Blubell Pharma Group Company
  • Cadila Pharmaceuticals
  • Caesar & Loretz Gmbh
  • Cipla Limited
  • Estrellas Life Sciences Private Limited
  • Fagron Industry
  • Glenmark Pharmaceuticals
  • Intas Pharmaceuticals Ltd.
  • Lupin Limited
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Shandong Octagon Chemicals Limited
  • Shanghai Yijing Industrial Co., Ltd.
  • Sigmak Life Sciences
  • Sofgen Pharmaceuticals Llc
  • Teva Pharmaceuticals Industries Ltd.
  • Virtus Pharmaceuticals Llc
  • Wuhan Honor Bio-Pharm Co., Ltd.
Product Code: MRR-E3708867712D

The Progesterone Market was valued at USD 1.30 billion in 2023, expected to reach USD 1.47 billion in 2024, and is projected to grow at a CAGR of 13.39%, to USD 3.14 billion by 2030.

Progesterone, a vital hormone in the reproductive system, plays a critical role in regulating the menstrual cycle, maintaining pregnancy, and has applications in various medical treatments. The necessity of progesterone extends beyond its physiological roles; it's crucial for hormone replacement therapy, contraceptives, and treatment of menstrual disorders and certain cancers. The end-use scope spans across pharmaceuticals, biotechnology, and even veterinary sectors, reflecting its diverse utility. Market insights indicate that the growing awareness of reproductive health, increasing gynecological disorders, and advancements in drug delivery systems are pivotal growth factors in the progesterone market. The rising demand for bio-identical hormones and natural progesterone represents significant market opportunities, as does the potential for expanding applications in newer therapeutic areas. Companies could capture these opportunities by investing in innovative drug formulations and delivery technologies, ensuring compliance with regulatory standards, and focusing on consumer education regarding hormone therapies. However, the market is not without challenges. Stringent regulatory requirements, side effects associated with synthetic variants, and competition from alternative therapies pose notable limitations. Price sensitivity in emerging markets and complex supply chain dynamics for raw materials also hinder growth potential. To overcome these challenges, there's a need for increased research into safer, more efficient synthetic and bio-identical progesterone formulations. Moreover, advancements in personalized medicine and biotechnology present fertile ground for innovation. The nature of the market is competitive yet ripe with opportunities for businesses that can navigate these complexities through strategic partnerships, focusing on niche markets, and leveraging technology to improve product efficacy and safety. By anticipating regulatory changes and aligning product offerings with consumer preferences, companies can sustain growth and capitalize on emerging trends in the progesterone market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.30 billion
Estimated Year [2024] USD 1.47 billion
Forecast Year [2030] USD 3.14 billion
CAGR (%) 13.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Progesterone Market

The Progesterone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of amenorrhea, breast cancer, and AIDS
    • Growing female infertility rates all over the globe
    • Increasing demand owing to different gynecological treatment
  • Market Restraints
    • Concern associated with side effects of progesterone and progestin
  • Market Opportunities
    • Technological advancements in the medical field
    • Ongoing research and development activities
  • Market Challenges
    • Lack of awareness about hormone therapy

Porter's Five Forces: A Strategic Tool for Navigating the Progesterone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Progesterone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Progesterone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Progesterone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Progesterone Market

A detailed market share analysis in the Progesterone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Progesterone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Progesterone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Progesterone Market

A strategic analysis of the Progesterone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Progesterone Market, highlighting leading vendors and their innovative profiles. These include Alkem Laboratories Ltd., Aquatic Remedies Pvt. Ltd, Bionpharma, Inc., Blubell Pharma Group Company, Cadila Pharmaceuticals, Caesar & Loretz Gmbh, Cipla Limited, Estrellas Life Sciences Private Limited, Fagron Industry, Glenmark Pharmaceuticals, Intas Pharmaceuticals Ltd., Lupin Limited, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Shandong Octagon Chemicals Limited, Shanghai Yijing Industrial Co., Ltd., Sigmak Life Sciences, Sofgen Pharmaceuticals Llc, Teva Pharmaceuticals Industries Ltd., Virtus Pharmaceuticals Llc, and Wuhan Honor Bio-Pharm Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Progesterone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Natural Progesterone and Synthetic Progesterone.
  • Based on Mode of Delivery, market is studied across Injectable, Oral, and Suspended Form.
  • Based on Application, market is studied across Contraception, Dysfunctional Uterine Bleeding, Endometrial Cancer, Hyperplastic Precursor Lesions, and Regulation of the Menstrual Cycle.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of amenorrhea, breast cancer, and AIDS
      • 5.1.1.2. Growing female infertility rates all over the globe
      • 5.1.1.3. Increasing demand owing to different gynecological treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with side effects of progesterone and progestin
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the medical field
      • 5.1.3.2. Ongoing research and development activities
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about hormone therapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Progesterone Market, by Type

  • 6.1. Introduction
  • 6.2. Natural Progesterone
  • 6.3. Synthetic Progesterone

7. Progesterone Market, by Mode of Delivery

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Suspended Form

8. Progesterone Market, by Application

  • 8.1. Introduction
  • 8.2. Contraception
  • 8.3. Dysfunctional Uterine Bleeding
  • 8.4. Endometrial Cancer
  • 8.5. Hyperplastic Precursor Lesions
  • 8.6. Regulation of the Menstrual Cycle

9. Americas Progesterone Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Progesterone Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Progesterone Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alkem Laboratories Ltd.
  • 2. Aquatic Remedies Pvt. Ltd
  • 3. Bionpharma, Inc.
  • 4. Blubell Pharma Group Company
  • 5. Cadila Pharmaceuticals
  • 6. Caesar & Loretz Gmbh
  • 7. Cipla Limited
  • 8. Estrellas Life Sciences Private Limited
  • 9. Fagron Industry
  • 10. Glenmark Pharmaceuticals
  • 11. Intas Pharmaceuticals Ltd.
  • 12. Lupin Limited
  • 13. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • 14. Shandong Octagon Chemicals Limited
  • 15. Shanghai Yijing Industrial Co., Ltd.
  • 16. Sigmak Life Sciences
  • 17. Sofgen Pharmaceuticals Llc
  • 18. Teva Pharmaceuticals Industries Ltd.
  • 19. Virtus Pharmaceuticals Llc
  • 20. Wuhan Honor Bio-Pharm Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PROGESTERONE MARKET RESEARCH PROCESS
  • FIGURE 2. PROGESTERONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PROGESTERONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PROGESTERONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PROGESTERONE MARKET DYNAMICS
  • TABLE 7. GLOBAL PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PROGESTERONE MARKET SIZE, BY NATURAL PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PROGESTERONE MARKET SIZE, BY SYNTHETIC PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PROGESTERONE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PROGESTERONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PROGESTERONE MARKET SIZE, BY SUSPENDED FORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PROGESTERONE MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PROGESTERONE MARKET SIZE, BY DYSFUNCTIONAL UTERINE BLEEDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PROGESTERONE MARKET SIZE, BY ENDOMETRIAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PROGESTERONE MARKET SIZE, BY HYPERPLASTIC PRECURSOR LESIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PROGESTERONE MARKET SIZE, BY REGULATION OF THE MENSTRUAL CYCLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES PROGESTERONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. PROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. PROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023